CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. REFERENCES 1, , , . Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57: 1333–1342. 2, , . Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013; 13: 123–135. 3, . Hepatitis C virus infection. N Engl J Med. 2001; 345: 41–52. 4, , , , , , et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.